NUTX on Nasdaq

Nutex Health Inc.

American business services company based in Houston, incorporated in Delaware. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with XBP Global Holdings, Inc., Andersen Group Inc. or Payoneer, or pick any stock.

  • TickerNUTX on Nasdaq1
  • IndustryServices-Business Services, NEC1
  • HeadquartersHouston, Texas1
  • Incorporated inDE2
  • Business address1776 Yorktown St, Suite 700, Houston, Tx 770562
  • Filer categoryAccelerated filer2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Nutex Health Inc. (“Nutex Health” or the “Company”) is a physician-led, healthcare services and operations company with 26 hospital facilities (as of December 31, 2025) in 12 states (hospital division), and a primary care-centric, risk-bearing population health management division. Our hospital division implements and operates innovative health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (“HOPDs”). The population health management (“PHM”) division owns and operates provider networks such as independent physician associations (“IPAs”).3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

50.8%Gross margin4
31.5%Operating margin4
8.1%Net margin4
82.4%Revenue growth, 20254
21.5%Return on equity4
0.09×Debt to equity4
$245.6MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Hospital Division brought in 96% of the revenue Nutex Health Inc. broke down this way in fiscal 2025.

  1. Hospital Division$844.2M496%up 88% from 2024
  2. Population Health Management Division$31.1M44%up 1% from 2024
Products and services by year
Products and services2022202320242025
Hospital Division$198.5M$218.1M$449.1M$844.2M
Population Health Management Division$20.8M$29.6M$30.9M$31.1M

Business segments

Hospital Division brought in 96% of the revenue Nutex Health Inc. broke down this way in fiscal 2025.

  1. Hospital Division$844.2M496%up 88% from 2024
  2. Population Health Management Division$31.1M44%up 1% from 2024
Business segments by year
Business segments2022202320242025
Hospital Division$198.5M$218.1M$449.1M$844.2M
Population Health Management Division$20.8M$29.6M$30.9M$31.1M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Other costs85¢$740.0M
  • Income tax7¢$64.4M
  • Profit8¢$70.8M

Out of $875.3M in revenue.4

Where each dollar of operating cash went, fiscal 2025

  • Capital spending1¢$2.5M
  • Share buybacks2¢$5.0M
  • Kept or used elsewhere97¢$240.6M

Out of $248.1M of cash from operations.4

Financial statements

Revenue56784$875.3M in 2025+63955% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $1.4M$1.4M20192020: $274.0M$274.0M2020+19955%2021: $331.5M$331.5M2021+21%2022: $219.3M$219.3M2022−34%2023: $247.6M$247.6M2023+13%2024: $479.9M$479.9M2024+94%2025: $875.3M$875.3M2025+82%
Gross profit56784$444.3M in 2025+82792% since 2019
0$200.0M$400.0M$600.0M2019: $536.0K$536.0K20192020: $157.6M$157.6M2020+29305%2021: $179.3M$179.3M2021+14%2022: $15.4M$15.4M2022−91%2023: $34.8M$34.8M2023+125%2024: $196.3M$196.3M2024+464%2025: $444.3M$444.3M2025+126%
Operating income56784$275.6M in 2025
-$600.0M-$400.0M-$200.0M0$200.0M$400.0M2019: -$6.9M-$6.9M20192020: $153.2M$153.2M20202021: $170.3M$170.3M2021+11%2022: -$406.6M-$406.6M20222023: -$31.8M-$31.8M2023−92%2024: $130.7M$130.7M20242025: $275.6M$275.6M2025+111%
Net income56784$70.8M in 2025
-$600.0M-$400.0M-$200.0M0$200.0M2019: -$7.1M-$7.1M20192020: $106.0M$106.0M20202021: $132.6M$132.6M2021+25%2022: -$424.8M-$424.8M20222023: -$45.8M-$45.8M2023−89%2024: $52.1M$52.1M20242025: $70.8M$70.8M2025+36%

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
Total revenue$875.3M$479.9M$247.6M
Payroll$158.1M$117.5M$108.4M
Contract services$190.3M$100.8M$42.4M
Medical supplies$17.2M$15.3M$14.2M
Depreciation and amortization$20.5M$19.0M$17.6M
Other$44.8M$31.1M$30.4M
Total operating costs and expenses$431.0M$283.7M$212.9M
Gross profit$444.3M$196.3M$34.8M
Facilities closing costs$0$0$217.0K
Acquisition costs$0$0$44.0K
Stock-based compensation$117.0M$16.6M$2.8M
Impairment of assets$0$3.9M$29.1M
Impairment of goodwill$0$3.2M$1.1M
General and administrative expenses$51.7M$41.9M$33.2M
Total corporate and other costs$168.7M$65.6M$66.5M
Operating income (loss)$275.6M$130.7M-$31.8M
Interest expense, net$22.2M$19.9M$16.3M
Loss on warrant liability$0$1.6M$0
Other (income) expense$8.6M-$669.0K$399.0K
Income (loss) before taxes$244.8M$109.8M-$48.5M
Income tax expense (benefit)$64.4M$15.0M-$5.1M
Net income (loss)$180.4M$94.8M-$43.4M
Less: net income attributable to noncontrolling interests$109.6M$42.7M$2.4M
Net income (loss) attributable to Nutex Health Inc.$70.8M$52.1M-$45.8M
Basic earnings (loss) per common share (in dollars per share)$11.13$10.23-$10.39
Diluted earnings (loss) per common share (in dollars per share)$10.48$9.69-$10.39

Compare Nutex Health Inc. with another company

Leadership

Who has led Nutex Health Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. John Salerno2010–2014
  2. Rory Welch2015–2016
  3. Jacob Margolin2019
  4. Lawrence Schimmel2020–2021
  5. Warren Hosseinion2021
  6. Thomas T. Vo2022–now

Chair

  1. John Salerno2010
  2. Thomas T. Vo2022

President

  1. John Salerno2010–2014
  2. Rory Welch2015–2016
  3. Frederick Sternberg2022
  4. Warren Hosseinion2022–now

Chief financial officer

  1. Elisa Luqman V.2010–2021
  2. Michael Bowen2022

Chief operating officer

  1. Claudia Denise Pufal2022
  2. Joshua Detillio2023–2025
  3. Wesley Shane Bamburg2025–now
201520202025
Board members and other officers (24)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerJon Bates named Oct 17, 202345
  • Executive Officer, DirectorWarren Hosseinionn named Oct 17, 202345
  • Executive OfficerDenise Pufal named Apr 12, 202246
  • Executive Officer, DirectorHosseinion Warren named Dec 15, 202147
  • DirectorJohn Waters named Dec 15, 2021 to Oct 17, 202345
  • DirectorMichael Reed named Apr 12, 2022 to Oct 17, 202345
  • DirectorBrandon Sims named Dec 15, 202147
  • DirectorTerrence Breslin named Dec 15, 202147

Former names

  • Nutex Health, Inc.Apr 4, 2022 to Feb 11, 20262
  • Clinigence Holdings, Inc.Nov 14, 2019 to Mar 31, 20222
  • iGambit, Inc.Dec 31, 2009 to Nov 13, 20192

Timeline

  1. Apr 5, 2022New chief executive Thomas T. Vo becomes CEO12
  2. Dec 21, 2021New chief executive Warren Hosseinion becomes CEO13
  3. Sep 9, 2020New chief executive Lawrence Schimmel becomes CEO14
  4. Nov 8, 2019New chief executive Jacob Margolin becomes CEO15
  5. Dec 14, 2015New chief executive Rory Welch becomes CEO16
  6. Mar 5, 2010New chief executive John Salerno becomes CEO17

Filings

283 filings to the SEC since October 2021: 9 annual reports, 16 quarterly reports, 71 major events, 119 insider forms, 13 large holders, 3 private raises, 52 other. The latest 20:

  1. Sep 22, 20268-A12B EDGAR
  2. Sep 22, 2026CERT EDGAR
  3. Sep 18, 20264 PRIMARY DOCUMENT EDGAR
  4. Sep 11, 20268-K EDGAR
  5. Aug 31, 20268-K EDGAR
  6. Aug 24, 20268-K EDGAR
  7. Aug 13, 20268-K EDGAR
  8. Aug 6, 20268-K EDGAR
  9. Aug 6, 202610-Q EDGAR
  10. Aug 3, 20264 PRIMARY DOCUMENT EDGAR
  11. Aug 3, 20264 PRIMARY DOCUMENT EDGAR
  12. Aug 3, 20264 PRIMARY DOCUMENT EDGAR
  13. Aug 3, 20264 PRIMARY DOCUMENT EDGAR
  14. Jul 21, 20268-K EDGAR
  15. Jun 4, 20264 PRIMARY DOCUMENT EDGAR
  16. May 29, 20264 PRIMARY DOCUMENT EDGAR
  17. May 7, 2026SCHEDULE 13G/A EDGAR
  18. Apr 30, 20268-K EDGAR
  19. Apr 30, 202610-Q EDGAR
  20. Apr 27, 2026SCHEDULE 13G EDGAR

The 283 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

43 open-market trades by officers, directors and large owners since October 2021: 31 buys and 12 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 18, 2026Saunders Scott JDirectorSale203$214.25$43.5KForm 4
Mar 20, 2026Jaumot Frank EDirectorBuy150$93.56$14.0KForm 4
Mar 19, 2026Hosseinion WarrenPresidentBuy252$94.07$23.7KForm 4
Mar 17, 2026Spears KelvinDirectorBuy10$94.46$945Form 4
Mar 13, 2026Montgomery Pamela W.Chief Legal Officer-HealthcareBuy79$88.87$7.0KForm 4
Nov 25, 2025Bates Jon ChristianChief Financial OfficerBuy750$136.71$102.5KForm 4
Apr 8, 2025Bates Jon ChristianChief Financial OfficerBuy1,000$81.81$81.8KForm 4
Aug 22, 2024Bates Jon ChristianChief Financial OfficerBuy1,350$21.46$29.0KForm 4
Aug 20, 2024DeTillio JoshuaChief Operating OfficerBuy575$17.40$10.0KForm 4
Aug 19, 2024DeTillio JoshuaChief Operating OfficerBuy1,300$17.85$23.2KForm 4
Jun 12, 2024DeTillio JoshuaChief Operating OfficerBuy20,000$0.54$10.8KForm 4
May 30, 2024Vo Thomas T.Chief Executive OfficerBuy2,986$0.66$2.0KForm 4
May 29, 2024Vo Thomas T.Chief Executive OfficerBuy3,768$0.68$2.6KForm 4
May 28, 2024Vo Thomas T.Chief Executive OfficerBuy48,394$0.70$33.9KForm 4
May 13, 2024Vo Thomas T.Chief Executive OfficerBuy17,330$0.69$12.0KForm 4
Nov 20, 2023Vo Thomas T.Chief Executive OfficerBuy275,200$0.23$63.3KForm 4
Nov 17, 2023Vo Thomas T.Chief Executive OfficerBuy224,800$0.23$51.7KForm 4
Nov 15, 2023DeTillio JoshuaChief Operating OfficerBuy140,000$0.24$33.6KForm 4
Aug 31, 2023Vo Thomas T.Chief Executive OfficerBuy152,326$0.28$42.7KForm 4
Aug 30, 2023Vo Thomas T.Chief Executive OfficerBuy305,947$0.31$94.8KForm 4

All 43 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 30, 2023Raised $3.1 million in a private offering of debt Form D: $15 million offered in all Form D
  2. Apr 1, 2022Raised $2.4 billion in a private offering of equity Form D: 123 investors so far Form D
  3. May 14, 2021Raised $11.3 million in a private offering of equity Form D: 73 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Pertento Partners LLP451,310$77.1M5.5%+77,340
BlackRock, Inc.407,349$69.6M0.0%+27,994
American Century Companies Inc237,414$40.6M0.0%+33,964
Vanguard Capital Management LLC215,919$36.9M0.0%−3,212
Geode Capital Management, LLC132,049$22.6M0.0%+9,936
State Street Corp130,836$22.4M0.0%+7,659
D. E. Shaw & Co., Inc.97,454$16.7M0.0%New
UBS Group AG77,912$13.3M0.0%+8,342
Winmill & Co. Inc65,350$11.2M2.5%No change
Focus Partners Wealth60,881$10.4M0.0%New
Millennium Management LLC52,107$8.9M0.0%−37,464
Goldman Sachs Group Inc51,244$8.8M0.0%+17,449
Bridgeway Capital Management, LLC46,924$8.0M0.1%+31,904
Empowered Funds, LLC45,177$7.7M0.0%+12,726
Northern Trust Corp44,056$7.5M0.0%+2,789
Topline Capital Management, LLC41,764$7.1M1.9%−136,036
One Plus One Wealth Management, LLC40,441$6.9M3.0%No change
Vanguard Fiduciary Trust Co35,969$6.1M0.0%+141
Vanguard Portfolio Management LLC34,660$5.9M0.0%−5,143
Victory Capital Management Inc29,190$5.0M0.0%−15,944
Truist Financial Corp26,814$4.6M0.0%+492
Los Angeles Capital Management LLC25,151$4.3M0.0%−6,908
Bank of New York Mellon Corp23,151$4.0M0.0%+1,529
Barclays PLC22,485$3.8M0.0%+4,598
Jpmorgan Chase & Co20,004$3.4M0.0%−447

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53